| Literature DB >> 24892739 |
Andrea Vannini1, Davide Roncarati1, Marco Spinsanti1, Vincenzo Scarlato1, Alberto Danielli1.
Abstract
The severity of symptoms elicited by the widespread human pathogen Helicobacter pylori is strongly influenced by the genetic diversity of the infecting strain. Among the most important pathogen factors that carry an increased risk for gastric cancer are specific genotypes of the cag pathogenicity island (cag-PAI), encoding a type IV secretion system (T4SS) responsible for the translocation of the CagA effector oncoprotein. To date, little is known about the regulatory events important for the expression of a functional cag-T4SS. Here we demonstrate that the cag-PAI cistrons are subjected to a complex network of direct and indirect transcriptional regulations. We show that promoters of cag operons encoding structural T4SS components display homogeneous transcript levels, while promoters of cag operons encoding accessory factors vary considerably in their basal transcription levels and responses. Most cag promoters are transcriptionally responsive to growth-phase, pH and other stress-factors, although in many cases in a pleiotropic fashion. Interestingly, transcription from the Pcagζ promoter controlling the expression of transglycolase and T4SS stabilizing factors, is triggered by co-culture with a gastric cell line, providing an explanation for the increased formation of the secretion system observed upon bacterial contact with host cells. Finally, we demonstrate that the highly transcribed cagA oncogene is repressed by iron limitation through a direct apo-Fur regulation mechanism. Together the results shed light on regulatory aspects of the cag-PAI, which may be involved in relevant molecular and etiological aspects of H. pylori pathogenesis.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24892739 PMCID: PMC4043881 DOI: 10.1371/journal.pone.0098416
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Strains and plasmid used in this study.
| Strain or Plasmid | Genotype or description | Source or reference |
|
| ||
| DH5α | supE44 ΔlacU169 (Φ80 lacZΔM15) hsdR17 recA1 endA1 gyrA96 thi-1 relA1β | |
|
| ||
| G27 | Clinical isolate; wild-type parental strain | |
| G27( | G27 derivative; bp 25 to 434 of the |
|
| G27( | G27 derivative; bp 88 to 417 of the |
|
| G27( | G27 derivative; bp 66 to 334 of the |
|
| G27( | G27 derivative; bp 156 to 375 of the |
|
| G27( | G27 derivative; bp 3 to 1290 of the | This study |
| G27 | G27 derivative carrying the |
|
| G27 |
| This study |
| G27 |
| This study |
| G27 |
| This study |
| G27 |
| This study |
| G27 |
| This study |
| G27 |
| This study |
| G27 |
| This study |
| G27 |
| This study |
| G27 |
| This study |
| G27 |
| This study |
| G27 |
| This study |
| G27 |
| This study |
| G27 |
| This study |
| G27 |
| This study |
| G27 |
| This study |
| G27 |
| This study |
| G27 |
| This study |
| G27 |
| This study |
| G27 |
| This study |
| G27 |
| This study |
| G27 |
| This study |
| G27 |
| This study |
| Plasmids | ||
| pBluescript KS II | Cloning vector, ApR | Stratagene |
| pGEM-T Easy | Cloning vector, ApR | Promega |
| pBS:: | pBluescript KS II derivative carrying a |
|
| pBS::Δ | pBluescript KS II derivative, carrying a 460 bp XbaI-BglII fragment amplified on chromosomal DNA of | This study |
| pGEM-P | pGEM-T Easy derivative, carrying a 403 bp fragment amplified on chromosomal DNA of | This study |
| pVCC | Suicide transformation vector for promoter- |
|
| PVCC::P | pVCC derivative carrying a 122 bp BamHI/BglII fragment amplified on chromosomal DNA of | This study |
| PVCC::P | pVCC derivative carrying a 166 bp BamHI/BglII fragment from Lux519F and Lux520RL oligos, encompassing 115 bp of the P | This study |
| PVCC::P | pVCC derivative carrying a 306 bp BamHI/BglII fragment from VS530FS and VS531RL oligos, encompassing 300 bp of the P | This study |
| PVCC::P | pVCC derivative carrying a 366 bp BamHI/BglII fragment from VS530FL and VS531RS oligos, encompassing 269 bp of the P | This study |
| PVCC::P | pVCC derivative carrying a 366 bp BamHI/BglII fragment from VS530FL and VS531RS oligos, encompassing 361 bp of the P | This study |
| PVCC::P | pVCC derivative carrying a 306 bp BamHI/BglII fragment from VS530FS and VS531RL oligos, encompassing 270 bp of the P | This study |
| PVCC::P | pVCC derivative carrying a 180 bp BamHI/BglII fragment from VS534FS and VS534R2 oligos, encompassing 177 bp of the P | This study |
| PVCC::P | pVCC derivative carrying a 241 bp BamHI/BglII fragment from VS534F and VS534R2 oligos, encompassing 177 bp of the P | This study |
| PVCC::P | pVCC derivative carrying a 304 bp BamHI/BglII fragment from VS535FS and VS535R oligos, encompassing 301 bp of the P | This study |
| PVCC::P | pVCC derivative carrying a 439 bp BamHI/BglII fragment from VS535F and VS535R oligos, encompassing 301 bp of the P | This study |
| PVCC::P | pVCC derivative carrying a 204 bp BamHI/BglII fragment from VS536FS and VS537RL oligos, encompassing 201 bp of the P | This study |
| PVCC::P | pVCC derivative carrying a 394 bp BamHI/BglII fragment from VS536FL and Lux537R2 oligos, encompassing 170 bp of the P | This study |
| PVCC::P | pVCC derivative carrying a 394 bp BamHI/BglII fragment from VS536FL and Lux537R2 oligos, encompassing 388 bp of the P | This study |
| PVCC::P | pVCC derivative carrying a 204 bp BamHI/BglII fragment from VS536FS and VS537RL oligos, encompassing 167 bp of the P | This study |
| PVCC::P | pVCC derivative carrying a 308 bp BamHI/BglII fragment from VS543FS and VS543R oligos, encompassing 305 bp of the P | This study |
| PVCC::P | pVCC derivative carrying a 352 bp BamHI/BglII fragment from VS543F and VS543R oligos, encompassing 305 bp of the P | This study |
| PVCC::P | pVCC derivative carrying a 276 bp BamHI/BamHI fragment VS546FS and VS546R oligos, encompassing 274 bp of the P | This study |
| PVCC::P | pVCC derivative carrying a 300 bp BamHI/BamHI fragment from VS546F and VS546R oligos, encompassing 274 bp of the P | This study |
| PVCC::P | pVCC derivative carrying a 261 bp BamHI/BglII fragment from VSorfxFS and VS547RL oligos, encompassing 257 bp of the P | This study |
| PVCC::P | pVCC derivative carrying a 324 bp BamHI/BglII fragment from VSorfxFL and VS547RS oligos, encompassing 155 bp of the P | This study |
| PVCC::P | pVCC derivative carrying a 324 bp BamHI/BglII fragment from VSorfxFL and VS547RS oligos, encompassing 321 bp of the P | This study |
| PVCC::P | pVCC derivative carrying a 261 bp BamHI/BglII fragment from VSorfxFS and VS547RL oligos, encompassing 156 bp of the P | This study |
Primers used for cloning of the promoter regions and for primer extension reactions.
| Name | Sequence (5'-3') | Source | Restriction site |
| 520pe2 |
| This study | - |
| 530pe1 |
| This study | - |
| 531pe4 |
| This study | - |
| 534pe3 |
| This study | - |
| 535pe1 |
| This study | - |
| 536pe17 |
| This study | - |
| 537pe8 |
| This study | - |
| 543pe3 |
| This study | - |
| 546pe1 |
| This study | - |
| OrfX |
|
| - |
| cagN |
|
| - |
| 163f_Xba |
| This study | Xba |
| 163r_Bgl |
| This study | BglII |
| 166f_Bgl |
| This study | BglII |
| 166r_Hin |
| This study | HindIII |
| Lux519F |
| This study | BglII |
| VS520RS |
| This study | BamHI |
| VS520RL |
| This study | BamHI |
| VS530FS |
| This study | BamHI |
| VS530FL |
| This study | BamHI |
| VS531RS |
| This study | BglII |
| VS531RL |
| This study | BglII |
| VS534FS |
| This study | BamHI |
| VS534F |
| This study | BamHI |
| VS534R2 |
| This study | BglII |
| VS535FS |
| This study | BamHI |
| VS535F |
| This study | BamHI |
| VS535R |
| This study | BglII |
| VS536FS |
| This study | BamHI |
| VS536FL |
| This study | BamHI |
| Lux537R2 |
|
| BglII |
| VS537RL |
| This study | BglII |
| VS543FS |
| This study | BamHI |
| VS543F |
| This study | BamHI |
| VS543R |
| This study | BglII |
| VS546FS |
| This study | BamHI |
| VS546F |
| This study | BamHI |
| VS546R |
| This study | BamHI |
| VSOrfXFS |
| This study | BamHI |
| VSOrfXFL |
| This study | BamHI |
| VS547RS |
| This study | BglII |
| VS547RL |
| This study | BglII |
| Lux546F |
| This study | - |
| Lux547R |
| This study | - |
Restriction site added for cloning purposes are underlined.
Figure 1Mapping of cag promoters.
A. Genomic organization of the cag pathogenicity island in the H. pylori G27 strain. (1) Transcriptional units mapped in this study; black: plus strand; grey: minus strand. (2) Annotated cag genes and ORFs; white block arrow: ORF encoding effector toxin CagA; dark grey block arrows: ORFs encoding structural T4SS components; light grey block arrows: ORFs encoding components with ancillary or unknown function. (3) Alphabetic classification of cag genes. (4) Numeric classification of cag genes. (5) Annotation of cag genes in reference strain 26695. (6) Transcriptional start sites mapped in [20]. (7) Transcriptional units identified in [17], [33]. (8) Transcriptional units identified by unbiased promoter-trapping experiments in [30] B. Summary of relevant features within the nucleotide sequences of the Pcag promoters mapped in this study. The TSSs (+1) are boxed in black boxes and showed in boldface. Sequences corresponding to -10 regions, the extended TGn elements and recognizable -35 region are enlightened in grey boxes. C. Comparison of the transcript levels at the Pcag promoters fused with lux reporter genes. mRNA levels of the Pcag-lux constructs were assayed by primer extension analysis using the oligonucleotide VSluxC1 and quantified with a phospoimager. The mean values from three independent experiments are reported as arbitrary units of 32P counts.
Figure 2Growth phase-dependent regulation of cag promoters.
The Pcag promoters are reported according to the variations of the transcript levels during bacterial growth, with promoters induced at late logarithmic phase (A), repressed during bacterial growth (B) and not sensitive to growth phase-dependent (C). An overnight culture of wild type strain was diluted to an OD600 of 0.08 and cultured for 15 hours. Total RNAs were extracted from equal volumes of cultures at different time points corresponding to OD600 of 0.22 (t1), 0.53(t2), 1.06(t3) and 1.75(t4). Results from the primer extension analysis are shown in the upper panels. The normalized average intensities of the bands from three independent experiments are reported in the graphs as the n-fold change, with error bars indicating the standard deviation.
Figure 3Stress responses of cag promoters.
A. Heat-shock response of the Pcag promoters. Primer extension analyses were performed on total RNA extracted from bacterial cultures of H. pylori wild type strain grown to exponentially phase and maintained at 37°C or exposed to 42°C for 30 min. B. Iron-dependent regulation of the PcagA promoter. Liquid cultures of wild type and Δfur strains were grown to OD600 = 0.5 or OD600 = 1.7 and treated for 30 min with 1 mM (NH4)2Fe(SO4)2 (Fe+), or 100 µM 2,2-dipyridyl (Fe-). mRNA levels at the PcagA promoter were assayed by quantitative primer extension on the total RNA extracted. C. In vitro binding of Fur protein to the PcagB-PcagA promoter region in a DNaseI footprinting assay. Concentrations of Fur dimer, 0 nM (lane 1), 21 nM (lane 2), 42 nM (lane 3), 84 nM (lane 4), 168 nM (lane 5) and 336 nM (lane 6). The binding reaction was performed in a final volume of 50 µL in presence of divalent iron ions as cofactors (150 µM (NH4)2Fe(SO4)2). The vertical grey and black bars on the right of the panel (I-IV) indicate the areas of partial and complete DNaseI protection, respectively, resulting from binding of Fur on the probe. Fur binds to nucleotide positions +2 to -14 (I), -20 to -63 (II), -108 to -115 (III) and -145 to -188 (IV) with respect to the +1 transcriptional start site (TSS) of PcagA. An hypersensitivity band that appears at high concentrations of Fur is indicated by a black triangle. On the left side of the panel, the TSS downstream PcagB and PcagA are indicated with bent arrows, while the relative position of the -10 and -35 regions of the 2 promoters are indicated as vertical black boxes. G+A: G+A sequencing reaction ladder. D. DNaseI footprinting of Fur protein to the PcagB-PcagA promoter region without the supplement of iron ions and with 150 µM 2,2-dipyridyl used to sequester the Fe2+ ions. The experimental conditions used for the footprinting assay are the same as described in panel C.
Figure 4pH-dependent response of cag promoters.
Primer extension analyses were performed on total RNA extracted from bacterial cultures of H. pylori wild type strain, grown to exponential phase and treated for 30 or 90 min with 22 mM HCl to adjust the pH of the medium to 5.2, or maintained at neutral pH (pH 7.0). The intensity of the bands of four independent experiments were quantified and reported in the graphs as n-fold variation of the transcript levels in the acidic-treated samples with respect to the untreated sample. A. Pcag promoters with transcript levels increased after an acidic treatment for 30 min; B. Promoters with reduced mRNA levels after the 30 min acidic treatment; C. Promoters with unchanged transcript levels after the treatment. Error bars indicate the standard deviation and significant variations between treated and untreated samples are marked with asterisks (P<0.05). D. Response of PcagV, PcagQ, PcagP, PcagM and PcagC promoters after an acidic treatment of 90 min.
Figure 5Acid-dependent response of cag promoters in Δfur, ΔnikR and ΔarsS mutant strains.
Cultures were grown to exponential phase and exposed to acid-shock (pH = 5.2) for 30 min. Transcript levels at the Pcagζ, PcagU, PcagF, PcagA, PcagS and PcagB promoters were assayed by quantitative primer extensions. Asterisks mark the significant differences of n-fold variations deriving from the average band intensity of three independent primer extension experiments. Error bars indicate the standard deviation.
Figure 6Reporter assays with the Pcag-lux strains in host cell co-cultures.
Liquid cultures of Pcagζ-, PcagQ- and PcagB-lux strains were added at a multiplicity of infection of 5 to 24-wells plates containing human gastric adenocarcinoma (AGS) cells or with the medium only. The luminescence emitted by the reporter strains was recorded by a multilabel reader at regular intervals. Signals were normalized on the samples without AGS cells and averaged. Standard errors were calculated from four independent experiments (each in four technical replicates).
Figure 7Comparison of the Pcag-lux and Pcag-5′UTR-lux reporter signals.
A. Schematic representation of the Pcag-lux and Pcag-5′UTR-lux fusion constructs, obtained transforming the G27lux acceptor strain with the PVCC vector. The promoter sequences with or without the 5′untranslated regions (5′UTRs) carried by the pVCC vector are inserted upstream the luxCDABE operon by double homologous recombination and selected by cat chloramphenicol resistance. B. Luminescence signals from three independent experiments were normalized according to the optical density of the cultures and the means values were reported in the graph, with Pcag-lux signals on the X-axis and Pcag-5′UTR-lux signals on the Y-axis. Error bars indicate the standard deviation. A dashed line was added to the graph, corresponding to the 1∶1 ratio of the two signals. Grey dots: cag promoters with 1∶1 signal ratio; black dots: cag promoters with altered Pcag-lux/Pcag-5′UTR-lux signal ratio.